US Patent 7968717 Crystalline anhydrate with anticholinergic efficacy
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+308 characters)
Article
Patent abstract
The invention relates to a new crystalline anhydrate of tiotropium bromide, processes for preparing it and its use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Peter Sieger0
Waldemar Pfrengle0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07968717 Crystalline anhydrate with anticholinergic efficacy US Patent 7968717 Crystalline anhydrate with anticholinergic efficacy
Infobox
Patent Number
079687170
Patent Number
79687170
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079687170
Date of Patent
June 28, 2011
0Patent Application Number
109766240
Date Filed
October 29, 2004
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07968717 Crystalline anhydrate with anticholinergic efficacy
Infobox
Is a
Patent jurisdiction
Patent number
07968717
Date of patent
June 28, 2011
Patent application number
10976624
Date Filed
October 29, 2004
Patent primary examiner
Find more entities like US Patent 7968717 Crystalline anhydrate with anticholinergic efficacy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.